Loading...
At this year's Gastrointestinal Cancers Symposium, held January 23–25 in San Francisco, investigators discussed the latest findings in gastrointestinal cancer research. NEJM Journal Watch Oncology and Hematology Associate Editor David H. Ilson, MD, PhD, reviewed the following presentations on new treatments for gastrointestinal cancer. All abstracts can be viewed in the symposium's meeting library.
Tempero and colleagues presented results from the HALO 109-301 study (abstract 638, an industry-sponsored, randomized, double-blind, placebo-controlled, phase III trial of pegvorhyaluronidase (PEGPH20) — an agent that degrades hyaluronic acid in the tumor microenvironment — for previous…